ENTRY       D01199                      Drug
NAME        Emtricitabine (JAN/USAN/INN);
            Emtriva (TN)
  ABBR      FTC
PRODUCT     EMTRIVA (Gilead Sciences)
  GENERIC   EMTRICITABINE (Aurobindo Pharma Limited)
            EMTRICITABINE (Cipla USA)
            EMTRICITABINE (REMEDYREPACK)
FORMULA     C8H10FN3O3S
EXACT_MASS  247.0427
MOL_WEIGHT  247.2467
CLASS       Antiviral
             DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
             DG01440  Arabinofuranosyl type antiviral
             DG03107  Anti-HIV agent
              DG01656  HIV reverse transcriptase inhibitor
            Transporter substrate
             DG02860  SLC22A8 substrate
REMARK      Same as: C12599
            Therapeutic category: 6250
            ATC code: J05AF09
            Product: D01199<JP/US>
            Product (mixture): D02297<JP/US> D10571<US> D10755<JP/US> D10756<US> D10835<JP/US> D10836<JP/US> D10851<US> D11039<JP/US> D11382<JP/US>
EFFICACY    Antiviral, Reverse transcriptase inhibitor
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K24802)  Viral life cycle - HIV-1
METABOLISM  Transporter: SLC22A8 [HSA:9376]
INTERACTION  
STR_MAP     map07053  Anti-HIV agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
                 J05AF09 Emtricitabine
                  D01199  Emtricitabine (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)
               Emtricitabine
                D01199  Emtricitabine (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D01199  Emtricitabine (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Antiviral
              DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
               D01199  Emtricitabine
              DG01440  Arabinofuranosyl type antiviral
               D01199  Emtricitabine
              DG03107  Anti-HIV agent
               DG01656  HIV reverse transcriptase inhibitor
                D01199  Emtricitabine
             Transporter substrate
              DG02860  SLC22A8 substrate
               D01199  Emtricitabine
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D01199  Emtricitabine
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D01199  Emtricitabine (JAN/USAN/INN) &lt;JP/US&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D01199  Emtricitabine (JAN/USAN/INN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01199
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01199
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01199
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01199
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D01199
DBLINKS     CAS: 143491-57-0
            PubChem: 7848262
            ChEBI: 31536
            PDB-CCD: ETV
            LigandBox: D01199
ATOM        16
            1   N4y N    25.0103  -17.6390
            2   C1y C    23.6350  -18.1111
            3   C1y C    21.3970  -18.1111
            4   C1b C    20.1381  -17.4117
            5   O1a O    18.9492  -18.1111
            6   S2x S    21.8166  -19.4399
            7   O2x O    22.5160  -17.2718
            8   C1x C    23.2154  -19.4399
            9   C8x C    25.0206  -16.2402
            10  C8y C    26.2146  -15.5496
            11  C8y C    27.4684  -16.2582
            12  N5x N    27.4581  -17.6570
            13  C8y C    26.2641  -18.3476
            14  N1a N    28.6624  -15.5676
            15  X   F    26.1549  -14.1509
            16  O5x O    26.2538  -19.7463
BOND        17
            1     8   6 1
            2     4   5 1
            3     2   1 1 #Down
            4     3   4 1 #Down
            5     6   3 1
            6     1   9 1
            7     9  10 2
            8    10  11 1
            9    11  12 2
            10   12  13 1
            11   13   1 1
            12    3   7 1
            13   11  14 1
            14    7   2 1
            15   10  15 1
            16    2   8 1
            17   13  16 2
///
